Structure via PubChem · Public domain (PubChem)
levobetaxolol
Sign in to saveAlso known as (-)-betaxolol, (S)-betaxolol, AL-1577A, Betaxon®, (S)-1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol
Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).
Chemical data
- Formula
- C18H29NO3
- Molecular weight
- 307.4 g/mol
- IUPAC name
- (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol
- SMILES
- CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O
- InChIKey
- NWIUTZDMDHAVTP-KRWDZBQOSA-N
- XLogP
- 2.8
- Polar surface area
- 50.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2000
- Admin. routes
- topical
via ChEMBL · EBI
Wikidata facts
- Subclass of
- betaxolol
- Mass
- 307.214744
- Has use
- medication
Show 5 more facts
- chemical formula
- C₁₈H₂₉NO₃
- canonical SMILES
- CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
- isomeric SMILES
- CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O
- World Health Organisation international non-proprietary name
- levobetaxolol
- physically interacts with
- adrenoceptor beta 2
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
5 sectionsContents
- Indications
- Effect
- Contraindications and side effects
- History
- References
Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).
== Indications == It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular hypertension.
Excerpted from Wikipedia’s “levobetaxolol” article, available under the CC BY-SA 4.0 licence.